Avian leukosis viruses (ALVs) constitute a group of closely related retroviruses that are transmitted in chickens by endogenous proviral DNA as well as by exogenous infection. Naturally occurring ALVs are classified into five subgroups (A, B, C, D, and E) on the basis of viral envelope gp85 determinants which use specific host-encoded receptors. Subgroup A, B, C, and D envelope antigens are found in isolates of exogenous viruses, while subgroup E envelope antigens are characteristic of endogenous viruses (25) . Receptors for subgroup B and E (and possibly D) viruses are thought to be encoded by a series of alleles at the tv-b locus, with each allele encoding a receptor with unique affinities for B and E viruses (7) . Receptors for A virus are encoded at the tv-a locus. ALVs also differ in the transcriptional control elements found within their long terminal repeat (LTR) sequences, with the LTR of the endogenous virus RAV-0 promoting less-efficient virus growth in cultured chicken embryo fibroblasts (CEFs) than the LTRs of exogenous viruses (26) . To test for effects of envelope and LTR sequences on the tissue tropisms of ALVs, we have evaluated the relative growth of a series of in vitro-constructed ALVs in a variety of tissues.
Recombinant viruses were constructed from the molecularly cloned DNAs of RAV-1 and RAV-0 (Fig. 1) . RAV-1 is a subgroup A virus isolated from stocks of the Bryan high-titer strain of Rous sarcoma virus, in which it serves as a helper for the defective sarcoma virus (19) . It induces a high incidence of B-cell lymphoma and a low incidence of a variety of other neoplasms in day-old inoculated chickens (18) . RAV-0 is a subgroup E virus encoded by the endogenous virus which resides at ev 2 (1). It appears to be very low in pathogenicity, since little disease has been observed to follow RAV-0 inoculation of susceptible day-old chicks (6, 15) . Viruses were recovered from constructed DNAs by transfection into turkey cells (12) and were verified for subgroup by testing for interference with superinfection by RAV-0 or RAV-1 pseudotypes of Rous sarcoma virus (29) . The growth of the test viruses on K28 CEFs was determined; * Corresponding author.
CEFs were infected with undiluted virus stocks and passed three times (approximately 10 days in culture) before being harvested by trypsinization. Fibroblasts were then assayed for the amount of total protein (5) and for the amount of virus capsid protein p27 by using a solid-phase enzyme-linked immunosorbent assay (22) . The results of these tests indicated that the viruses varied in their growth potential on CEFs, with RAV-1 growing the best and RAV-0 growing the least well (Fig. 1) . In general, the more RAV-1 information a recombinant contained, the better it grew on CEFs.
To evaluate tissue tropisms, groups of day-old K28 chicks were inoculated intravenously with 0.2 ml of undiluted stocks of the various recombinants and parental viruses. These stocks contained from 4 to 66% of the amount of p27 found in a standard stock of RAV-2 (6). K28 chickens can be infected by both subgroup A and E viruses (14, 17 b Values represent the concentration of virus capsid protein p27 in samples diluted to 50 ,ug of tissue protein per ml relative to the concentration of p27 in a RAV-2 culture medium x 104. Tissue homogenates were prepared by grinding in the presence of 0.8% deoxycholate, 0.8% Nonidet P-40, 10 ,ug of aprotinin per ml, and 2 mM phenylmethylsulfonyl fluoride. The amounts of p27 were determined by using an enzyme-linked immunosorbent assay. The initial coat consisted of a monoclonal antibody for capsid p27 antigen. Microtiter wells were blocked with 2% bovine serum albumin in carbonate buffer and incubated with samples diluted in phosphate-buffered saline containing 1% bovine serum albumin and 0.1% Tween 20 (Sigma Chemical Co., St. Louis, Mo.). Bound p27 was then detected by using a rabbit anti-capsid antiserum followed by an alkaline phosphatase conjugate of goat anti-rabbit immunoglobulin G (Cooper Biomedical, Inc., Cochranville, Pa.) and finally by the para-nitrophenyl phosphate substrate for alkaline phosphatase. A405 was determined by using a Bio-Tek EL-307.
Thymus. The thymotropism associated with subgroup B and E viruses could be a major contributing factor to the immunosuppression associated with some subgroup B ALVs (20, 23) . We have found that the thymotropic virus RAV-2 does not cause generalized immunosuppression but does very effectively induce tolerance (work in progress).
Skeletal muscle. The subgroup A virus muscle tropism could in part explain the occurrence of a muscle disease induced by recombinant ring-necked pheasant viruses with subgroup A but not subgroup F envelope antigens (21) . The finding of high levels of replication in the skeletal muscle of chicks inoculated after hatching (Tables 1 and 2 ) is intriguing because postembryonic skeletal muscle growth involves cell enlargement rather than cell division (11, 24) and host cell DNA replication is thought to be required for integration and expression of viral genes (27, 28) .
Bursa. High levels of viral replication were detected in the bursas of line 63 chickens (Table 2) , a line known for its resistance to ALV-induced lymphoma induction (4) . Also, in the lymphoma-susceptible line K28, the levels of viral replication in the bursa at 1 to 2 months of age did not correlate well with lymphoma induction (6, 15) . However, the extent b Amount of p27 relative to that in a RAV-2 standard stock x 104. Tissue homogenates were tested as described in Table 1 , footnote b. The presence of p27 in tissues from the uninfected control is attributed to gag expression by the endogenous virus locus ev 3, present in line 63 (2) . NT, Not tested.
of viral replication in the bursas of K28 chicks during the first 3 weeks post-hatch does correlate with lymphoma induction (6) .
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